about
Dopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older peopleEpistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control study.Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty.Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke.Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.Effects of paliperidone palmitate on coagulation: an experimental study.
P2860
Q28476572-D9B81EF5-9542-4F0E-A1FC-76D32688CCC5Q33399574-7475513F-BF48-42AC-94F3-8761AADE0F2AQ34182611-F5AC1554-133F-41D3-9D84-4F8AF278A2F2Q35270090-2E692B9C-5881-466E-A3DE-102CBA1D7B60Q36295778-76061382-C6A9-4971-9751-860A900A643EQ38183266-DDECB464-2A1B-4A9A-8957-A518DE37DD28Q38207875-2F8C095E-898A-40C4-8237-482B5E83A6AEQ38402064-35302484-95FA-4DAB-B3BA-D8AC440FC737Q38987620-6B0682A7-FCA7-456A-8D66-42D48A10D427Q40772245-45DBA50C-5A80-4D94-B48D-85EBA8891DB5Q47864318-357F145E-D605-4F25-B5A0-4CB18091656DQ48638145-55BEDE21-7B0B-4D95-AF39-7EE7641641F4Q51143654-8B6DA63D-A28B-43CC-9671-97039FE1C477
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Use of serotonergic drugs and the risk of bleeding.
@en
Use of serotonergic drugs and the risk of bleeding.
@nl
type
label
Use of serotonergic drugs and the risk of bleeding.
@en
Use of serotonergic drugs and the risk of bleeding.
@nl
prefLabel
Use of serotonergic drugs and the risk of bleeding.
@en
Use of serotonergic drugs and the risk of bleeding.
@nl
P2093
P2860
P356
P1476
Use of serotonergic drugs and the risk of bleeding.
@en
P2093
B M Verdel
E R Heerdink
H G M Leufkens
P C Souverein
S D Meenks
T C G Egberts
P2860
P2888
P356
10.1038/CLPT.2010.240
P407
P577
2010-11-24T00:00:00Z
P5875
P6179
1005280640